Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

190
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
190

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiac magnetic resonance imaging parameters predict new-onset symptoms of heart failure in hypertrophic cardiomyopathy.

ESC heart failure·2026
Same author

Alpha DaRT source activity confirmation using a reentrant well-type ionization chamber.

Medical physics·2026
Same author

Automated needle reconstruction for HDR prostate brachytherapy using a commercially compatible 3D-printed transrectal ultrasound sleeve with integrated EM tracking sensors.

Brachytherapy·2026
Same author

American Brachytherapy Society consensus guidelines for medical physics residency training endorsed by the American Association of Physicists in Medicine, Part I: High-dose-rate remote afterloader brachytherapy.

Brachytherapy·2026
Same author

AAPM task group 317 report: A joint AAPM and ESTRO report on brachytherapy catheter, needle, and applicator tracking technology.

Medical physics·2026
Same author

Incorporating Machine Learning Driven Factors in the Design of Electronic-triggers to Detect Diagnostic Errors in the Emergency Department.

Journal of patient safety·2025

Related Experiment Video

Updated: Oct 5, 2025

Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System
08:25

Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System

Published on: April 11, 2018

15.5K

A new optimization algorithm for HDR brachytherapy that improves DVH-based planning: Truncated Conditional

Victor W Wu1,2, Marina A Epelman1, Kalyan S Pasupathy3,4

  • 1Department of Industrial and Operations Engineering, University of Michigan, Ann Arbor, MI 48109, United States of America.

Biomedical Physics & Engineering Express
|February 1, 2022
PubMed
Summary

A new Truncated Conditional Value-at-Risk (TCVaR) optimization algorithm significantly improves dose-volume histogram (DVH) results in brachytherapy by excluding extreme dose voxels. TCVaR outperforms previous methods and commercial systems for HDR treatment planning.

Keywords:
DVH metricsconvex optimizationdata envelopment analysishigh-dose rate brachytherapymulticriteria optimizationvalue-at-risk

More Related Videos

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
11:38

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

Published on: July 3, 2014

47.0K
Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
05:18

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

1.5K

Related Experiment Videos

Last Updated: Oct 5, 2025

Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System
08:25

Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System

Published on: April 11, 2018

15.5K
Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
11:38

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

Published on: July 3, 2014

47.0K
Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
05:18

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

1.5K

Area of Science:

  • Medical Physics
  • Radiation Oncology
  • Computational Optimization

Background:

  • Brachytherapy involves complex, heterogeneous dose distributions requiring precise treatment planning.
  • Existing optimization algorithms, like Conditional Value-at-Risk (CVaR), have limitations in achieving optimal dose-volume histogram (DVH) metrics.
  • Gradient-based approaches often yield better DVH results than the prior mean dose approach (CVaR).

Purpose of the Study:

  • To introduce a novel optimization algorithm, Truncated Conditional Value-at-Risk (TCVaR), designed to enhance DVH outcomes in brachytherapy.
  • To address the limitations of the CVaR approach by refining the calculation of mean doses in DVH metric tails.
  • To evaluate the performance of TCVaR against existing methods and commercial treatment planning systems.

Main Methods:

  • Developed Truncated Conditional Value-at-Risk (TCVaR) by excluding extreme dose voxels (hottest/coldest) from DVH tail mean dose calculations.
  • Employed an iterative sequence of convex approximations to optimize the selection of excluded voxels.
  • Utilized Data Envelopment Analysis for parameter sensitivity assessment and comparison against commercially generated plans for prostate, breast, and cervix sites.

Main Results:

  • TCVaR demonstrated monotonic improvement over CVaR as the number of iterations increased.
  • TCVaR outperformed the Eclipse-Brachyvision Treatment Planning System (TPS), showing significant improvements in PTVD95% for equivalent organ-at-risk doses.
  • Specific improvements included up to 5% for prostate, 3% for breast, and 1% for cervix treatment sites.

Conclusions:

  • The novel TCVaR optimization algorithm yields superior DVH metrics in high-dose-rate (HDR) brachytherapy planning compared to prior convex optimization and commercial systems.
  • TCVaR is computationally efficient and offers potential as a primary optimization tool or for quality assurance in radiation oncology.
  • The algorithm's ability to refine DVH metrics makes it a valuable advancement for brachytherapy treatment planning.